- Dzik, W. H. (2006). “The NHLBI
Clinical Trials Network in transfusion
medicine and hemostasis: an overview.”
Journal of Clinical Apheresis;
21:57-59.
|
- George, J. N; Woodson, R. D; Kiss, J.
E; Kojouri, K.; Vesely, S. K (2006). “Rituximab
therapy for thrombotic thrombocytopenic
purpura: a proposed study of the Transfusion
Medicine/Hemostasis Clinical Trials Network
with a systematic review of rituximab
therapy for immune-mediated disorders”.
Journal of Clinical Apheresis;
21:49-56.
|
- Journeycake, J; Brambilla D; Ragni M.
(2005). “Central venous access device-related
infections in hemophilia (abstract).”
Blood; 106: 898A.
|
- Konkle, B. A. and Nemo, G. J. (2005).
"Defining effective therapies in
transfusion medicine and hemostasis: new
opportunities with the TMH Network."
Transfusion; 45(9): 1404-6.
|
- Segal, J. B. and Dzik, W. H. (2005).
"Paucity of studies to support that
abnormal coagulation test results predict
bleeding in the setting of invasive procedures:
an evidence-based review." Transfusion;
45(9): 1413-25.
|
- Slichter, S. J. (2006). “Background,
rationale, and design of a clinical trial
to assess the effects of platelet dose
on bleeding risk in thrombocytopenic patients.”
Journal of Clinical Apheresis;
21:78-84.
|
- Steiner, M. E; Key N.S; Levy J. H; (2005).
"Activated recombinant factor VII
in cardiac surgery." Current Opinion
in Anaesthesiology; 18(1): 89-92.
|
